RECOMMENDATION(S):
APPROVE clarification of Board action of February 13, 2018 (Item C.51), which authorized the Purchasing Agent to execute a purchase order with Beckman Coulter, Inc. in the amount of $253,395 for the purchase of the CellaVision DM9600 for the clinical laboratory at Contra Costa Regional Medical Center and Health Centers, to reflect the correct payment limit of $264,009.
FISCAL IMPACT:
Funded 100% by Hospital Enterprise Fund I.
BACKGROUND:
On February 13, 2018, the Board of Supervisors approved the Purchase Order with Beckman Coulter, Inc. in the amount of $253,395 for the purchase of the CellaVision DM9600 in order to process blood smears and body fluids. The purpose of this board order is to correct an administrative error in the total payment limit which should have read in an amount of $264,009 instead of $253,395.
CONSEQUENCE OF NEGATIVE ACTION:
If the correction to the purchase order is not approved, CCRMC will not be able to purchase the CellaVision DM9600 to process blood smears and body fluids for the laboratory.
|